Effects of DASH diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: A randomized clinical trial

Nutrition

Volumn 30, Issue 11-12, 2014, Pages 1287-1293

  Asemi, Zatollah ^a   Samimi, Mansooreh ^a   Tabassi, Zohreh ^a   Shakeri, Hossein ^a   Sabihi, Sima Sadat ^a   Esmaillzadeh, Ahmad ^b,c  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

DASH; Lipids; Oxidative stress; Polycystic ovary syndrome; Women

Indexed keywords

CARBOHYDRATE; FAT; GLUTATHIONE; INSULIN; PROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTIOXIDANT; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BODY MASS; CALORIC RESTRICTION; CLINICAL ARTICLE; CONTROLLED STUDY; DAIRY PRODUCT; DIET THERAPY; DIETARY APPROACHES TO STOP HYPERTENSION DIET; DIETARY COMPLIANCE; FEMALE; FRUIT; GRAIN; HUMAN; INSULIN BLOOD LEVEL; METABOLIC PARAMETERS; OBESITY; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PARALLEL DESIGN; PLASMA TOTAL ANTIOXIDANT CAPACITY; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; VEGETABLE; WEIGHT REDUCTION; ADOLESCENT; BLOOD; COMPLICATION; FEEDING BEHAVIOR; GLUCOSE BLOOD LEVEL; HYPERTENSION; INSULIN RESISTANCE; METABOLISM; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, VLDL; FEMALE; FOOD HABITS; GLUTATHIONE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; OBESITY; OVERWEIGHT; OXIDATIVE STRESS; POLYCYSTIC OVARY SYNDROME; TRIGLYCERIDES; YOUNG ADULT;

EID: 84908127687     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2014.03.008     Document Type: Article

References (59)

1. Sinawat S., Buppasiri P., Lumbiganon P., Pattanittum P. Long versus short course treatment with metformin and clomiphene citrate for ovulation induction in women with PCOS. Cochrane Database Syst Rev 2012, 10:CD006226.
2. Teede H.J., Joham A.E., Paul E., Moran L.J., Loxton D., Jolley D., et al. Longitudinal weight gain in women identified With polycystic ovary syndrome: Results of an observational study in young women. Obesity (Silver Spring) 2013, 21:1526-1532.
3. Mehrabian F., Khani B., Kelishadi R., Ghanbari E. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Pol 2011, 62:238-242.
4. Wild R.A. Dyslipidemia in PCOS. Steroids 2012, 77:295-299.
5. Gonzalez F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids 2012, 77:300-305.
6. Carmina E. Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome. Front Horm Res 2013, 40:40-50.
7. Essick E.E., Wilson R.M., Pimentel D.R., Shimano M., Baid S., Ouchi N., et al. Adiponectin modulates oxidative stress-induced autophagy in cardiomyocytes. PLoS One 2013, 8:e68697.
8. San Millan J.L., Corton M., Villuendas G., Sancho J., Peral B., Escobar-Morreale H.F. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. J Clin Endocrinol Metab 2004, 89:2640-2646.
9. McGowan M.P. Polycystic ovary syndrome: a common endocrine disorder and risk factor for vascular disease. Curr Treat Options Cardiovasc Med 2011, 13:289-301.
10. Fanta M. Is polycystic ovary syndrome, a state of relative estrogen excess, a real risk factor for estrogen-dependant malignancies?. Gynecol Endocrinol 2013, 29:145-147.
11. Hudecova M., Jan H., Christian B., Poromaa Inger S. Long-term reproductive and metabolic consequences of PCOS. Curr Diabetes Rev 2012, 8:444-451.
12. Costello M.F., Misso M.L., Wong J., Hart R., Rombauts L., Melder A., et al. The treatment of infertility in polycystic ovary syndrome: a brief update. Aust N Z J Obstet Gynaecol 2012, 52:400-403.
13. Motta A.B. The role of obesity in the development of polycystic ovary syndrome. Curr Pharm Des 2012, 18:2482-2491.
14. Harwood K., Vuguin P., DiMartino-Nardi J. Current approaches to the diagnosis and treatment of polycystic ovarian syndrome in youth. Horm Res 2007, 68:209-217.
15. Costello M.F., Ledger W.L. Evidence-based lifestyle and pharmacological management of infertility in women with polycystic ovary syndrome. Womens Health (Lond Engl) 2012, 8:277-290.
16. Galletly C., Moran L., Noakes M., Clifton P., Tomlinson L., Norman R. Psychological benefits of a high-protein, low-carbohydrate diet in obese womenwith polycystic ovary syndrome-a pilot study. Appetite 2007, 49:590-593.
17. Moran L.J., Noakes M., Clifton P.M., Tomlinson L., Galletly C., Norman R.J. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003, 88:812-819.
18. Herriot A.M., Whitcroft S., Jeanes Y. An retrospective audit of patients with polycystic ovary syndrome: the effects of a reduced glycaemic load diet. J Hum Nutr Diet 2008, 21:337-345.
19. Mehrabani H.H., Salehpour S., Amiri Z., Farahani S.J., Meyer B.J., Tahbaz F. Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study. J Am Coll Nutr 2012, 31:117-125.
20. Vollmer W.M., Sacks F.M., Ard J., Appel L.J., Bray G.A., Simons-Morton D.G., et al. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med 2001, 135:1019-1028.
21. Azadbakht L., Fard N.R., Karimi M., Baghaei M.H., Surkan P.J., Rahimi M., et al. Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial. Diabetes Care 2011, 34:55-57.
22. Asemi Z., Tabassi Z., Samimi M., Fahiminejad T., Esmaillzadeh A. Favourable effects of the Dietary Approaches to Stop Hypertension diet on glucose tolerance and lipid profiles in gestational diabetes: a randomised clinical trial. Br J Nutr 2013, 109:2024-2030.
23. Azadbakht L., Mirmiran P., Esmaillzadeh A., Azizi T., Azizi F. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care 2005, 28:2823-2831.
24. Aeberli I., Molinari L., Spinas G., Lehmann R., L'Allemand D., Zimmermann M.B. Dietary intakes of fat and antioxidant vitamins are predictors of subclinical inflammation in overweight Swiss children. Am J Clin Nutr 2006, 84:748-755.
25. Holt E.M., Steffen L.M., Moran A., Basu S., Steinberger J., Ross J.A., et al. Fruit and vegetable consumption and its relation to markers of inflammation and oxidative stress in adolescents. J Am Diet Assoc 2009, 109:414-421.
26. King D.E., Mainous A.G., Geesey M.E., Ellis T. Magnesium intake and serum C-reactive protein levels in children. Magnes Res 2007, 20:32-36.
27. Luo X., Xu L. [Association of fat distribution with metabolic syndrome in patients with polycystic ovary syndrome]. Nan Fang Yi Ke Da Xue Xue Bao 2012, 32:1325-1327.
28. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19-25.
29. Liang S.J., Hsu C.S., Tzeng C.R., Chen C.H., Hsu M.I. Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40. Hum Reprod 2011, 26:3443-3449.
30. Dettori J. The random allocation process: two things you need to know. Evid Based Spine Care J 2010, 1:7-9.
31. Zello G.A. Dietary Reference Intakes for the macronutrients and energy: considerations for physical activity. Appl Physiol Nutr Metab 2006, 31:74-79.
32. Benzie I.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996, 239:70-76.
33. Beutler E., Gelbart T. Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 1985, 105:581-584.
34. Saneei P., Hashemipour M., Kelishadi R., Rajaei S., Esmaillzadeh A. Effects of recommendations to follow the Dietary Approaches to Stop Hypertension (DASH) diet v. usual dietary advice on childhood metabolic syndrome: a randomised cross-over clinical trial. Br J Nutr 2013, 110:2250-2259.
35. Lin P.H., Yeh W.T., Svetkey L.P., Chuang S.Y., Chang Y.C., Wang C., et al. Dietary intakes consistent with the DASH dietary pattern reduce blood pressure increase with age and risk for stroke in a Chinese population. Asia Pac J Clin Nutr 2013, 22:482-491.
36. Kiddy D.S., Hamilton-Fairley D., Seppala M., Koistinen R., James V.H., Reed M.J., et al. Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I. Clin Endocrinol (Oxf) 1989, 31:757-763.
37. Hamilton-Fairley D., Kiddy D., Anyaoku V., Koistinen R., Seppala M., Franks S. Response of sex hormone binding globulin and insulin-like growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction. Clin Endocrinol (Oxf) 1993, 39:363-367.
38. Atiomo W., Daykin C.A. Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study. Mol Hum Reprod 2012, 18:546-553.
39. Murri M., Luque-Ramirez M., Insenser M., Ojeda-Ojeda M., Escobar-Morreale H.F. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update 2013, 19:268-288.
40. Champagne C.M. Magnesium in hypertension, cardiovascular disease, metabolic syndrome, and other conditions: a review. Nutr Clin Pract 2008, 23:142-151.
41. Doyle L., Cashman K.D. The effect of nutrient profiles of the Dietary Approaches to Stop Hypertension (DASH) diets on blood pressure and bone metabolism and composition in normotensive and hypertensive rats. Br J Nutr 2003, 89:713-724.
42. Harsha D.W., Sacks F.M., Obarzanek E., Svetkey L.P., Lin P.H., Bray G.A., et al. Effect of dietary sodium intake on blood lipids: results from the DASH-sodium trial. Hypertension 2004, 43:393-398.
43. Obarzanek E., Sacks F.M., Vollmer W.M., Bray G.A., Miller E.R., Lin P.H., et al. Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr 2001, 74:80-89.
44. Lomba A., Milagro F.I., Garcia-Diaz D.F., Campion J., Marzo F., Martinez J.A. A high-sucrose isocaloric pair-fed model induces obesity and impairs NDUFB6 gene function in rat adipose tissue. J Nutrigenet Nutrigenomics 2009, 2:267-272.
45. Jobgen W., Meininger C.J., Jobgen S.C., Li P., Lee M.J., Smith S.B., et al. Dietary L-arginine supplementation reduces white fat gain and enhances skeletal muscle and brown fat masses in diet-induced obese rats. J Nutr 2009, 139:230-237.
46. Cho H.J., Kang H.C., Choi S.A., Ju Y.C., Lee H.S., Park H.J. The possible role of Ca2+ on the activation of microsomal triglyceride transfer protein in rat hepatocytes. Biol Pharm Bull 2005, 28:1418-1423.
47. King J.L., Miller R.J., Blue J.P., O'Brien W.D., Erdman J.W. Inadequate dietary magnesium intake increases atherosclerotic plaque development in rabbits. Nutr Res 2009, 29:343-349.
48. Asemi Z., Samimi M., Tabassi Z., Sabihi S.S., Esmaillzadeh A. A randomized controlled clinical trial investigating the effect of DASH diet on insulin resistance, inflammation, and oxidative stress in gestational diabetes. Nutrition 2013, 29:619-624.
49. Lopes H.F., Martin K.L., Nashar K., Morrow J.D., Goodfriend T.L., Egan B.M. DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension 2003, 41:422-430.
50. Al-Solaiman Y., Jesri A., Zhao Y., Morrow J.D., Egan B.M. Low-sodium DASH reduces oxidative stress and improves vascular function in salt-sensitive humans. J Hum Hypertens 2009, 23:826-835.
51. Miller E.R., Erlinger T.P., Sacks F.M., Svetkey L.P., Charleston J., Lin P.H., et al. A dietary pattern that lowers oxidative stress increases antibodies to oxidized LDL: results from a randomized controlled feeding study. Atherosclerosis 2005, 183:175-182.
52. De Leo V., La Marca A., Cappelli V., Stendardi A., Focarelli R., Musacchio M.C., et al. [Evaluation of the treatment with D-chiroi-nositol on levels of oxidative stress in pcos patients]. Minerva Ginecol 2012, 64:531-538.
53. Avignon A., Hokayem M., Bisbal C., Lambert K. Dietary antioxidants: do they have a role to play in the ongoing fight against abnormal glucose metabolism?. Nutrition 2012, 28:715-721.
54. Puchau B., Zulet M.A., de Echavarri A.G., Hermsdorff H.H., Martinez J.A. Dietary total antioxidant capacity is negatively associated with some metabolic syndrome features in healthy young adults. Nutrition 2010, 26:534-541.
55. Chen X., Touyz R.M., Park J.B., Schiffrin E.L. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 2001, 38:606-611.
56. Fedirko V., Bostick R.M., Long Q., Flanders W.D., McCullough M.L., Sidelnikov E., et al. Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2010, 19:280-291.
57. Yang Y., Gao M., Nie W., Yuan J., Zhang B., Wang Z., et al. Dietary magnesium sulfate supplementation protects heat stress-induced oxidative damage by restoring the activities of anti-oxidative enzymes in broilers. Biol Trace Elem Res 2012, 146:53-58.
58. Hans C.P., Chaudhary D.P., Bansal D.D. Effect of magnesium supplementation on oxidative stress in alloxanic diabetic rats. Magnes Res 2003, 16:13-19.
59. Vasdev S., Gill V. The antihypertensive effect of arginine. Int J Angiol 2008, 17:7-22.